Bufencon

Bufencon

Manufacturer:

Y.S.P. Industries

Distributor:

Y.S.P. Industries
Concise Prescribing Info
Contents
Per mL Betamethasone dipropionate 5 mg, betamethasone disodium phosphate 2 mg
Indications/Uses
Rheumatic disorders, collagen disease, allergic states.
Dosage/Direction for Use
IM inj 1-2 mL. IA inj 0.25-1 mL, depending on joint size. Intradermal inj Max: 1 mL. Intralesional inj 0.25-1 mL, depending on lesion size.
Contraindications
Not for IV use. Systemic infections; inj into unstable joints, infected areas & intervertebral spaces. Childn <2 yr, neonates.
Special Precautions
Secondary adrenocortical insufficiency on long-term use. Local infections. Pregnancy & lactation.
Adverse Reactions
Fluid & electrolyte, musculoskeletal, GI, dermatologic, neurologic, endocrine, ophth & metabolic disturbances.
Drug Interactions
Reduced plasma level of salicylates. Metabolism altered by phenytoin. Increased clearance by phenobarb. Hyperglycaemic effect of betamethasone may offset the hypoglycaemic effect of oral antidiabetic drugs.
ATC Classification
H02AB01 - betamethasone ; Belongs to the class of glucocorticoids. Used in systemic corticosteroid preparations.
Presentation/Packing
Form
Bufencon inj
Packing/Price
5 mL x 10 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in